Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

henry schein inc. - HSIC

HSIC

Close Chg Chg %
66.57 2.32 3.49%

Closed Market

68.89

+2.32 (3.49%)

Volume: 2.11M

Last Updated:

May 8, 2025, 4:00 PM EDT

Trade Now

Company Overview: henry schein inc. - HSIC

HSIC Key Data

Open

$67.24

 Day Range

66.98 - 69.37

52 Week Range

60.56 - 82.49

 Market Cap

$8.10B

Shares Outstanding

121.72M

 Public Float

108.06M

Beta

0.87

 Rev. Per Employee

N/A

P/E Ratio

20.59

 EPS

$3.24

Yield

0.00%

 Dividend

$17.22

EX-DIVIDEND DATE

Feb 8, 2019

 SHORT INTEREST

N/A

AVERAGE VOLUME

1.44M

  

HSIC Performance

1 Week
 
 1.94%
 
1 Month
 
 3.27%
 
3 Months
 
 -15.73%
 
1 Year
 
 -9.19%
 
5 Years
 
 23.21%
 

HSIC Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 17
Full Ratings ➔

About henry schein inc. - HSIC

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

HSIC At a Glance

Henry Schein, Inc.
135 Duryea Road
Melville, New York 11747
Phone 1-631-843-5500 Revenue 12.67B
Industry Medical Distributors Net Income 390.00M
Sector Distribution Services 2024 Sales Growth 2.707%
Fiscal Year-end 12 / 2025 Employees 25,000
View SEC Filings

HSIC Valuation

P/E Current 20.591
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 22.663
Price to Sales Ratio 0.697
Price to Book Ratio 2.531
Price to Cash Flow Ratio 10.423
Enterprise Value to EBITDA 12.70
Enterprise Value to Sales 1.028
Total Debt to Enterprise Value 0.22

HSIC Efficiency

Revenue/Employee 506,920.00
Income Per Employee 15,600.00
Receivables Turnover 8.551
Total Asset Turnover 1.219

HSIC Liquidity

Current Ratio 1.421
Quick Ratio 0.775
Cash Ratio 0.044

HSIC Profitability

Gross Margin 29.709
Operating Margin 5.752
Pretax Margin 4.048
Net Margin 3.077
Return on Assets 3.752
Return on Equity 11.067
Return on Total Capital 6.227
Return on Invested Capital 6.852

HSIC Capital Structure

Total Debt to Total Equity 84.586
Total Debt to Total Capital 45.825
Total Debt to Total Assets 28.088
Long-Term Debt to Equity 61.568
Long-Term Debt to Total Capital 33.355
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Henry Schein Inc. - HSIC

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
12.40B 12.65B 12.34B 12.67B
Sales Growth
+22.55% +1.98% -2.44% +2.71%
Cost of Goods Sold (COGS) incl D&A
8.73B 9.00B 8.69B 8.91B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
209.53M 212.00M 248.00M 297.00M
Depreciation
70.40M 68.00M 70.00M 83.00M
Amortization of Intangibles
139.13M 144.00M 178.00M 214.00M
COGS Growth
+19.49% +3.08% -3.45% +2.53%
Gross Income
3.67B 3.65B 3.65B 3.77B
Gross Income Growth
+30.48% -0.63% +0.05% +3.12%
Gross Profit Margin
+29.61% +28.85% +29.59% +29.71%
2021 2022 2023 2024 5-year trend
SG&A Expense
2.82B 2.71B 2.94B 3.04B
Research & Development
- - - -
-
Other SG&A
2.82B 2.71B 2.94B 3.04B
SGA Growth
+25.39% -3.78% +8.34% +3.37%
Other Operating Expense
- - - -
-
Unusual Expense
3.15M 191.00M 126.00M 120.00M
EBIT after Unusual Expense
851.66M 747.00M 588.00M 609.00M
Non Operating Income/Expense
6.49M 18.00M 41.00M 35.00M
Non-Operating Interest Income
6.45M 17.00M 17.00M 24.00M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
27.60M 44.00M 87.00M 131.00M
Interest Expense Growth
-33.30% +59.42% +97.73% +50.57%
Gross Interest Expense
27.60M 44.00M 87.00M 131.00M
Interest Capitalized
- - - -
-
Pretax Income
830.55M 721.00M 542.00M 513.00M
Pretax Income Growth
+66.14% -13.19% -24.83% -5.35%
Pretax Margin
+6.70% +5.70% +4.39% +4.05%
Income Tax
197.35M 170.00M 120.00M 128.00M
Income Tax - Current - Domestic
165.58M 199.00M 100.00M 133.00M
Income Tax - Current - Foreign
42.75M 44.00M 40.00M 56.00M
Income Tax - Deferred - Domestic
(14.68M) (61.00M) 6.00M (41.00M)
Income Tax - Deferred - Foreign
3.70M (12.00M) (26.00M) (20.00M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
653.21M 566.00M 436.00M 398.00M
Minority Interest Expense
29.29M 28.00M 20.00M 8.00M
Net Income
623.91M 538.00M 416.00M 390.00M
Net Income Growth
+55.50% -13.77% -22.68% -6.25%
Net Margin Growth
+5.03% +4.25% +3.37% +3.08%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
623.91M 538.00M 416.00M 390.00M
Preferred Dividends
- - - -
-
Net Income Available to Common
623.91M 538.00M 416.00M 390.00M
EPS (Basic)
4.4536 3.954 3.1848 3.076
EPS (Basic) Growth
+57.79% -11.22% -19.45% -3.42%
Basic Shares Outstanding
140.09M 136.06M 130.62M 126.79M
EPS (Diluted)
4.4008 3.9055 3.1575 3.0521
EPS (Diluted) Growth
+56.90% -11.25% -19.15% -3.34%
Diluted Shares Outstanding
141.77M 137.76M 131.75M 127.78M
EBITDA
1.06B 1.15B 962.00M 1.03B
EBITDA Growth
+41.36% +8.05% -16.35% +6.65%
EBITDA Margin
+8.58% +9.09% +7.80% +8.10%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 76.154
Number of Ratings 17 Current Quarters Estimate 1.207
FY Report Date 06 / 2025 Current Year's Estimate 4.864
Last Quarter’s Earnings 1.15 Median PE on CY Estimate N/A
Year Ago Earnings 4.74 Next Fiscal Year Estimate 5.269
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 15 15 15 14
Mean Estimate 1.21 1.26 4.86 5.27
High Estimates 1.34 1.31 4.91 5.37
Low Estimate 1.14 1.22 4.81 5.20
Coefficient of Variance 4.43 2.29 0.60 0.87

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 5 5 5
OVERWEIGHT 1 1 1
HOLD 10 10 9
UNDERWEIGHT 0 0 0
SELL 1 1 1
MEAN Overweight Overweight Overweight

Insider Actions for Henry Schein Inc. - HSIC

Date Name Shares Transaction Value
Mar 21, 2025 Philip A. Laskaway Director 24,805 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $71.04 per share 1,762,147.20
Mar 21, 2025 Bradford C. Connett CEO, NA Distribution Group 62,688 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $71.15 per share 4,460,251.20
Mar 21, 2025 Michael Saul Ettinger EVP & Chief Operating Officer 103,693 Bona fide gift 0.00
Mar 21, 2025 Michael Saul Ettinger EVP & Chief Operating Officer 103,798 Bona fide gift 0.00
Mar 17, 2025 Stanley M. Bergman Chairman, CEO; Director 353,354 Bona fide gift 0.00
Mar 17, 2025 Mark E. Mlotek EVP, Chief Strategic Officer; Director 103,417 Bona fide gift 0.00
Mar 12, 2025 Andrea Albertini CEO, Global Dist. & Tech. 70,019 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 12, 2025 Ronald N. South SVP & Chief Financial Officer 88,328 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 12, 2025 Mark E. Mlotek EVP, Chief Strategic Officer; Director 103,757 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 12, 2025 James P. Breslawski President 206,542 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 12, 2025 Walter Siegel Sr. VP & Chief Legal Officer 47,189 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 12, 2025 Thomas C Popeck CEO, Henry Schein Products 36,792 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 7, 2025 Joseph L. Herring Director 27,748 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 7, 2025 Kurt P. Kuehn Director 18,474 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 7, 2025 Kurt P. Kuehn Director 15,630 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $70.31 per share 1,098,945.30
Mar 7, 2025 Carol Raphael Director 31,319 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $70.31 per share 2,202,038.89
Mar 7, 2025 Bradley T. Sheares Director 45,046 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 7, 2025 Reed Vaughn Tuckson Director 7,586 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $70.31 per share 533,371.66
Mar 7, 2025 Reed Vaughn Tuckson Director 10,430 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 7, 2025 Bradley T. Sheares Director 42,202 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $70.31 per share 2,967,222.62

Henry Schein Inc. in the News